Wipfli Financial Advisors’s Integra LifeSciences IART Stock Holding History

Wipfli Financial Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$29K	Buy	+681	New	+$34.9K	﹤0.01%	1393

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wipfli Financial Advisors's IART Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Integra LifeSciences (IART) in Q3 2022: 681 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #1393 among its holdings.

282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

Wipfli Financial Advisors held 681 shares of Integra LifeSciences worth $29K as of Q3 2022.
Integra LifeSciences was a new Wipfli Financial Advisors position in Q3 2022.
Integra LifeSciences made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1393 holding.
282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.